GB202003277D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number: GB202003277D0
Authority: GB; United Kingdom
Prior art keywords: therapeutic agents; therapeutic; agents
Prior art date: 2020-03-06
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB2003277.7A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Kings College London

Original Assignee

Kings College London

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2020-03-06

Filing date

2020-03-06

Publication date

2020-04-22

2020-03-06 Application filed by Kings College London filed Critical Kings College London

2020-03-06 Priority to GBGB2003277.7A priority Critical patent/GB202003277D0/en

2020-04-22 Publication of GB202003277D0 publication Critical patent/GB202003277D0/en

2021-03-05 Priority to PCT/EP2021/055566 priority patent/WO2021176042A1/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/10—Cellular immunotherapy characterised by the cell type used
- A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
- A61K40/31—Chimeric antigen receptors [CAR]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K40/00—Cellular immunotherapy
- A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
- A61K40/41—Vertebrate antigens
- A61K40/42—Cancer antigens
- A61K40/4202—Receptors, cell surface antigens or cell surface determinants
- A61K40/4203—Receptors for growth factors
- A61K40/4205—Her-2/neu/ErbB2, Her-3/ErbB3 or Her 4/ ErbB4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF], i.e. urogastrone
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/495—Transforming growth factor [TGF]
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C07K2319/41—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a Myc-tag
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
- C07K2319/43—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation containing a FLAG-tag

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Medicinal Chemistry (AREA)
Biophysics (AREA)
Immunology (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

GBGB2003277.7A 2020-03-06 2020-03-06 Therapeutic agents Ceased GB202003277D0 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
GBGB2003277.7A GB202003277D0 (en)	2020-03-06	2020-03-06	Therapeutic agents
PCT/EP2021/055566 WO2021176042A1 (en)	2020-03-06	2021-03-05	Therapeutic agents

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB2003277.7A GB202003277D0 (en)	2020-03-06	2020-03-06	Therapeutic agents

Publications (1)

Publication Number	Publication Date
GB202003277D0 true GB202003277D0 (en)	2020-04-22

Family

ID=70278386

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB2003277.7A Ceased GB202003277D0 (en)	2020-03-06	2020-03-06	Therapeutic agents

Country Status (2)

Country	Link
GB (1)	GB202003277D0 (en)
WO (1)	WO2021176042A1 (en)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4458066A (en)	1980-02-29	1984-07-03	University Patents, Inc.	Process for preparing polynucleotides
GB8601597D0 (en)	1986-01-23	1986-02-26	Wilson R H	Nucleotide sequences
GB8717430D0 (en)	1987-07-23	1987-08-26	Celltech Ltd	Recombinant dna product
GB8809129D0 (en)	1988-04-18	1988-05-18	Celltech Ltd	Recombinant dna methods vectors and host cells
NZ532896A (en)	2001-11-08	2007-08-31	Pdl Biopharma Inc	Stable liquid pharmaceutical formulation of IGG antibodies including daclizumab and fontolizumab
US7446190B2 (en) *	2002-05-28	2008-11-04	Sloan-Kettering Institute For Cancer Research	Nucleic acids encoding chimeric T cell receptors
TW200738261A (en)	2005-12-20	2007-10-16	Bristol Myers Squibb Co	Stable protein formulations
WO2008005983A2 (en) *	2006-07-06	2008-01-10	Molecular Logix, Inc.	Pan-her antagonists and methods of use
US9345661B2 (en)	2009-07-31	2016-05-24	Genentech, Inc.	Subcutaneous anti-HER2 antibody formulations and uses thereof
US20160280798A1 (en) *	2013-11-06	2016-09-29	The United States Of America, As Represented By The Secretary Department Of Health & Human Service	Alk antibodies, conjugates, and chimeric antigen receptors, and their use
GB201513540D0 (en)	2015-07-31	2015-09-16	King S College London	Therapeutic agents
CN106967173A (en) *	2016-01-13	2017-07-21	上海嘉和生物科技有限公司	The chimeric memebrane protein of one kind restructuring and its preparation and application
EP3336107A1 (en) *	2016-12-15	2018-06-20	Miltenyi Biotec GmbH	Immune cells expressing an antigen binding receptor and a chimeric costimulatory receptor
WO2019226998A1 (en) *	2018-05-25	2019-11-28	The Regents Of The University Of California	Genetic engineering of endogenous proteins

2020
- 2020-03-06 GB GBGB2003277.7A patent/GB202003277D0/en not_active Ceased
2021
- 2021-03-05 WO PCT/EP2021/055566 patent/WO2021176042A1/en not_active Ceased

Also Published As

Publication number	Publication date
WO2021176042A1 (en)	2021-09-10

Publication	Publication Date	Title
GB201909190D0 (en)	2019-08-07	Therapeutic agents
GB201909191D0 (en)	2019-08-07	Therapeutic agents
GB201909194D0 (en)	2019-08-07	Therapeutic agents
GB201902277D0 (en)	2019-04-03	Therapeutic agents
GB202210731D0 (en)	2022-09-07	Therapeutic agents
GB201906804D0 (en)	2019-06-26	Therapeutic agents
GB202109583D0 (en)	2021-08-18	Therapeutic agents
GB202010606D0 (en)	2020-08-26	Therapeutic agents
GB202115770D0 (en)	2021-12-15	Therapeutic agents
GB202115366D0 (en)	2021-12-08	therapeutic agents
GB202114792D0 (en)	2021-12-01	Therapeutic agents
GB202114507D0 (en)	2021-11-24	Therapeutic agents
GB202114429D0 (en)	2021-11-24	Therapeutic agents
GB202112860D0 (en)	2021-10-27	Therapeutic agents
GB202111639D0 (en)	2021-09-29	Therapeutic agents
GB202110567D0 (en)	2021-09-08	Therapeutic agents
GB202110120D0 (en)	2021-08-25	Therapeutic agents
GB202109520D0 (en)	2021-08-18	Therapeutic agents
GB202108945D0 (en)	2021-08-04	Therapeutic agents
GB202019702D0 (en)	2021-01-27	Therapeutic agents
GB202017641D0 (en)	2020-12-23	Therapeutic agents
GB202017640D0 (en)	2020-12-23	Therapeutic agents
GB202012731D0 (en)	2020-09-30	Therapeutic agents
GB202012481D0 (en)	2020-09-23	Therapeutic agents
GB202012501D0 (en)	2020-09-23	Therapeutic agents

Legal Events

Date	Code	Title	Description
2021-05-19	AT	Applications terminated before publication under section 16(1)